Evidence map›Paper›PMID 39468631›Full record

ArticleInfectious diseases of poverty2024

Molecular characterisation of human rabies in Tanzania and Kenya: a case series report and phylogenetic investigation.

Gurdeep Jaswant, Kathryn Campbell, Anna Czupryna, Athman Mwatondo, Brian Ogoti, Carmen W E Embregts, Corine H GeurtsvanKessel, Charles Kayuki, Davis Kuchaka, Gati Wambura and 16 more

Abstract readCase Reports
In one paragraph

Article in Infectious diseases of poverty, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Gurdeep Jaswant *Faculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya. gurdeepjaswant14@gmail.com.ORCID http://orcid.org/0000-0002-5027-454X
Kathryn Campbell *School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
Anna CzuprynaSchool of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
Athman MwatondoZoonotic Disease Unit, Ministry of Health and Ministry of Livestock, Nairobi, 00202, Kenya.
Brian OgotiFaculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya.
Carmen W E EmbregtsViroscience Department, Erasmus MC Rotterdam, Rotterdam, 3015 CN, the Netherlands.
Corine H GeurtsvanKesselViroscience Department, Erasmus MC Rotterdam, Rotterdam, 3015 CN, the Netherlands.
Charles KayukiOxford Nanopore Technologies, Gosling Building, Edmund Halley Road, Oxford Science Park, Oxford, OX4 4DQ, UK.
Davis KuchakaBiotechnology Laboratory, Kilimanjaro Clinical Research Institute, P. O. Box 2236, Moshi, Tanzania.
Gati WamburaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, 40100, Kenya.
James OigoCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, 40100, Kenya.
Joel ChangaluchaEnvironmental Health & Ecological Sciences, Ifakara Health Institute, Plot 463, Dar Es Salaam, Tanzania.
Julius O OyugiFaculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya.
Kennedy LushasiEnvironmental Health & Ecological Sciences, Ifakara Health Institute, Plot 463, Dar Es Salaam, Tanzania.
Lwitiko SikanaEnvironmental Health & Ecological Sciences, Ifakara Health Institute, Plot 463, Dar Es Salaam, Tanzania.
Marco van ZwetselaarBiotechnology Laboratory, Kilimanjaro Clinical Research Institute, P. O. Box 2236, Moshi, Tanzania.
Marieke C J DekkerBiotechnology Laboratory, Kilimanjaro Clinical Research Institute, P. O. Box 2236, Moshi, Tanzania.
Mathew MuturiZoonotic Disease Unit, Ministry of Health and Ministry of Livestock, Nairobi, 00202, Kenya.
Marybeth MaritimDepartment of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, 00202, Kenya.
Mumbua MutungaFaculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya.
Rowan DurrantSchool of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
Tom AbalaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, 40100, Kenya.
Veronicah ChuchuCenter for Epidemiological Modelling & Analysis, University of Nairobi, Nairobi, 00202, Kenya.
Kirstyn Brunker *School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
S M Thumbi *Faculty of Health Sciences, Institute of Tropical & Infectious Diseases, University of Nairobi, Nairobi, 00202, Kenya.
Katie Hampson *School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.

Funding

Zoonotic and Emerging Infectious Diseases Training ProgramD43TW011519 · FIC · WASHINGTON STATE UNIVERSITY · PI Walter Godfrey Jaoko, Thumbi Mwangi · 2020 to 2026
$1.2M
FIC NIH HHS D43 TW011519Medical Research Council MR/X002047/1National Institute for Health and Care Research, Global Health Research Group on the Application of Genomics and Modelling to the Control of Virus Pathogens (GeMVi) in East Africa at the University of Warwickellowship 176382Wellcome TrustWellcome Trust 110330Wellcome Trust 204820Wellcome Trust 207569/Z/17/ZWellcome Trust 224670/Z/21/Z
6 · The paper itself

Abstract

backgroundRabies remains a major public health problem in low- and middle-income countries. However, human rabies deaths are rarely laboratory-confirmed or sequenced, especially in Africa. Five human rabies deaths from Tanzania and Kenya were investigated and the causative rabies viruses sequenced, with the aim of identifying implications for rabies control at individual, healthcare and societal levels. CASE PRESENTATION: The epidemiological context and care of these cases was contrasting. Four had a clear history of being bitten by dogs, while one had an unclear biting history. Two individuals sought medical attention within a day of being bitten, whereas three sought care only after developing rabies symptoms. Despite seeking medical care, none of the cases received complete post-exposure prophylaxis: one patient received only tetanus vaccination, one did not complete the post-exposure vaccination regimen, one followed an off-label vaccination schedule, and two did not receive any post-exposure vaccinations before the onset of symptoms. These cases highlight serious gaps in health-seeking behaviour, and in health systems providing appropriate care following risky exposures, including in the accessibility and effectiveness of post-exposure prophylaxis as it is administered in the region.

conclusionsThe viral genomic and epidemiological data confirms dog-mediated rabies as the cause of each of these deaths. The phylogenetic investigation highlights the transboundary circulation of rabies within domestic dog populations, revealing distinct rabies virus clades with evidence of regional spread. These findings underscore the importance of coordinated cross-border control efforts between the two countries. Urgent action is needed to improve awareness around the need for emergency post-exposure vaccines that should be accessible in local communities and administered appropriately, as well as investment in coordinated dog vaccination to control dog-mediated rabies, the underlying cause of these deaths.

Indexed as

PhylogenyRabiesRabies virusAnimalsBites and StingsDog DiseasesDogsHumansKenyaPost-Exposure ProphylaxisRabies VaccinesTanzaniaRabies VaccinesEast AfricaGenomic surveillanceLyssavirusNanoporeNext-generation sequencingOne HealthWhole genome sequencing

Identifiers

PMID39468631
PMCPMC11514914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.